NCT02489526View on ClinicalTrials.gov

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 28, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 15, 2016

Conditions
Post-Operative Pain
Interventions
DRUG

VVZ-149 Injections

Experimental group will receive a loading dose of 1.8 mg/kg VVZ-149 intravenous infusion for 0.5 hour followed by a maintenance dose of 1.3 mg/kg/h VVZ-149 intravenous infusion for 7.5 hours.

DRUG

Placebo

Placebo group will receive the corresponding amount of placebo.

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Vivozon, Inc.

INDUSTRY

NCT02489526 - Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Colorectal Surgery | Biotech Hunter | Biotech Hunter